Quarterly Result15 May 2026, 07:32 pm
KIMS Ltd Approves Audited Results for Q4 & FY26
AI Summary
Krishna Institute of Medical Sciences Ltd (KIMS) has announced the approval of its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board also appointed M/s. Sagar & Associates as Cost Auditors for FY 2026-27 and approved the re-designation of Mr. Adwik Bollineni as Executive & Non Independent Director. The 24th Annual General Meeting will be held on August 27, 2026. The results are available on the company website and stock exchange platforms.
Key Highlights
- Audited standalone and consolidated financial results for Q4 and FY26 approved.
- S.R. Batliboi & Associates LLP issued an unmodified opinion on the audited financial results.
- M/s. Sagar & Associates appointed as Cost Auditors for FY 2026-27.
- Mr. Adwik Bollineni re-designated as Executive & Non Independent Director.
- 24th Annual General Meeting scheduled for August 27, 2026.
Price Impact
More from KIMS